Piramal Pharma Ltd. (PPLPHARMA) Share Price Rises 2.11% Today

Piramal Pharma Ltd. Share Price rose to Rs 217.7, up 2.11% today, taking market capitalisation to Rs 28,550.76 crore.

Piramal Pharma Ltd. Share Price was in focus on 02 September 2026 after the stock climbed Rs 4.5 to Rs 217.7 from the previous close of Rs 213.2. The stock opened at Rs 211.05, traded between Rs 211.05 and Rs 217.7, and turnover stood at Rs 3.39 crore. The supplied data confirms a same-day rise, but it does not identify a company-specific trigger, so the useful lens is price behaviour plus the company’s valuation and profitability profile.

That profile is mixed. The company’s market capitalisation of Rs 28,550.76 crore is well above the same-industry median market cap of Rs 720.34 crore and above the same-industry average of Rs 14,208.71 crore across 201 benchmark companies. However, profitability remains weak on the supplied numbers: ROE is -4.04, ROCE is 1.24, EPS is Rs -2.36 and dividend yield is 0. Its P/B ratio is 3.55 against an industry median of 2.88 and industry average of 4.35, which places valuation above the middle of the benchmark set on book value, even though return metrics trail industry norms.

Piramal Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 217.7
Previous Close	Rs 213.2
Today's Move	Rs 4.5 (+2.11%)
Open	Rs 211.05
High	Rs 217.7
Low	Rs 211.05
Turnover	Rs 3.39 crore
Market Capitalisation	Rs 28,550.76 crore
Market Cap Category	Large Cap

Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 217.7 from the previous close of Rs 213.2, a move of Rs 4.5 or 2.11%. The stock opened at Rs 211.05, reached a high of Rs 217.7, recorded a low of Rs 211.05.

Piramal Pharma Ltd. Share Price moved higher through the session. From an open of Rs 211.05, the stock rose to an intraday high of Rs 217.7, which was also the current price in the supplied snapshot. The day’s low was Rs 211.05, matching the open, which means the stock advanced from the session floor and stayed above the previous close of Rs 213.2.

In percentage terms, the move was 2.11%, or Rs 4.5. That is a notable one-day gain, especially because the price finished at the top of the intraday range available in the dataset. Turnover of Rs 3.39 crore shows that the move was accompanied by measurable activity, though the data provided does not support any conclusion beyond that.

For readers watching daily momentum rather than long-term forecasts, the important takeaway is simple: buyers lifted the stock from Rs 211.05 to Rs 217.7 in the same session, and the counter held its gains above the prior close. That explains why Piramal Pharma Ltd. Share Price is appearing on intraday watchlists today even without a confirmed event catalyst in the source data.

Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 28,550.76 crore
P/B Ratio	3.55x
ROE	-4.04%
ROCE	1.24%
EPS	Rs -2.36
Book Value Per Share	Rs 60.13
Dividend Yield	0%

Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P/B 3.55x, ROE -4.04%, ROCE 1.24%. These figures provide context only and are not a buy or sell signal.

Piramal Pharma Ltd. has a market capitalisation of Rs 28550.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.55x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	31.29x
Benchmark Average P/E	48.12x
Benchmark P/E Range	3.68x to 653.31x
Company P/B Ratio	3.55x
Benchmark Median P/B	2.88x
Company ROE	-4.04%
Benchmark Median ROE	11.79%
Company ROCE	1.24%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 28,550.76 crore
Benchmark Median Market Cap	Rs 720.34 crore

Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.79%, a difference of -134.27%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.63%, a difference of -90.9%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,69,309.92	38.29	5.36	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,425.7	83.18	13.77	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,347.12	86.48	21.02	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,919.92	25.73	4.31	19.69	21.39
Cipla Ltd.	CIPLA	1,14,392.76	33.99	3.26	11.83	16

Its ROE of -4.04% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 28,550.76 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Piramal Pharma Ltd.

• The stock rose Rs 4.5, or 2.11%, to Rs 217.7 today.
• It opened at Rs 211.05 and reached Rs 217.7, the day’s high.
• Turnover stood at Rs 3.39 crore.
• Market capitalisation of Rs 28,550.76 crore is above the industry average of Rs 14,208.71 crore and median of Rs 720.34 crore.
• P/B of 3.55 is above the industry median of 2.88, while ROE of -4.04 and ROCE of 1.24 lag benchmark and peer levels.

About Piramal Pharma Ltd.

Piramal Pharma Ltd. is part of the Healthcare sector and Pharmaceuticals & Drugs industry. The supplied dataset does not include segment details, product categories or revenue mix, so this article stays anchored to verified market and ratio data only. Based on that data, the company is a significant listed pharma name by market capitalisation, but one whose current return metrics trail both the industry benchmark and the displayed peer group.

Track Piramal Pharma Ltd. Share Price on Univest

Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Piramal Pharma Ltd. Share Price on Univest for live price updates, valuation metrics and peer context. You can also use the Univest top gainers screener and browse Univest market blogs for related market coverage.

Frequently Asked Questions

Why is Piramal Pharma Ltd. Share Price rising today?

Ans. Piramal Pharma Ltd. Share Price rose 2.11% to Rs 217.7 from the previous close of Rs 213.2. The supplied data confirms the price rise but does not identify a company-specific catalyst.

What is Piramal Pharma Ltd. Share Price today?

Ans. Piramal Pharma Ltd. Share Price today is Rs 217.7. The stock opened at Rs 211.05, touched a high of Rs 217.7, recorded a low of Rs 211.05 and was up Rs 4.5 in the session.

How do the fundamentals compare with the industry?

Ans. The company’s P/B is 3.55 versus the same-industry median of 2.88, but ROE of -4.04 and ROCE of 1.24 are below the industry medians of 11.79 and 13.63. Market cap of Rs 28,550.76 crore is above the industry average of.

How does Piramal Pharma Ltd. compare with key peers?

Ans. Compared with Sun Pharma, Divi's, Torrent, Zydus and Cipla, the company is smaller on market cap than all 5 displayed peers and weaker on ROE and ROCE than each of them. Its P/B of 3.55 is lower than Sun Pharma.